Investors

Investors image

News

Jan.08, 2026 Release
Approval for Cefiderocol in China
Dec.23, 2025 Release
Announcement of the Conclusion of a Joint Research & Development Agreement and Investment Agreement with Salubritas Therapeutics Aimed at Demonstrating the Improvements of Hearing Function through Hair Cell Regeneration and Creating Innovative Pharmaceuticals
Dec.22, 2025 Release
Shionogi Expands Rare Disease Presence with Planned Acquisition of Global Rights to Tanabe Pharma Corporation’s RADICAVA ORS® (edaravone) and IV RADICAVA
Dec.22, 2025 Release
Shionogi Receives Approval in Japan to Manufacture and Market ZURZUVAE® Capsules 30 mg for the Treatment of Major Depressive Disorder
Dec.15, 2025 Notice
Presentation Materials and Transcript of Sustainability Meeting
  • Latest IR Information

    ・Financial Results / Supplement

    　- Presentation material

    　- Transcript

    more
  • IR Library

    ・Financial Results / Supplement

    ・Presentation materials

    ・Annual Report / Integrated Report / EHS Report

    ・Corporate Governance Report

    ・Pipeline

    ・Fact Book

    more
  • Management Policy

    ・Philosophy

    ・Business Plan

    ・Corporate Governance

    ・Disclosure Policy

    ・Business Risks

    more
  • Shareholder Information

    ・Information on Shares

    ・General Meeting of Shareholders

    ・Analyst Coverage

    ・Bonds & Ratings

    more
  • Individual Investors

    ・Pharmaceutical Business

    ・Shionogi's Strength

    ・Business Strategy

    ・Business Activities, etc.

     

    more
  • Sustainability

    View the Shionogi's approach to sustainable growth

    more
  • Financial Highlights

    Financial highlights for the last five years

    more
  • IR Calendar

    The schedule and results of IR events in each fiscal year

     

    more